I don't want to breach any protocol , but I think we all have an interest in any good news and positive signs concerning neuropathy treatment . In that regard I do follow any news in the bio tech sector which provides more than just a "glimmer of hope". I do this not only for my own health reasons, but for investment reasons as well. So with that disclaimer ,some of you might be interested in the work going on at Sangamo BioSciences. It looks kike they stand a very good chance of success in developing not only a therapy for neuropathy pain but also nerve regeneration. With the baby boomers aging there is a huge market on the horizon for new and better neuropathy treatment, and if there is a dollar to be made......well, you know the rest of that saying. At any rate ,I hope this provides a little uplift to someones day. ps---they have had good success in phase 1 and are now in phase 2 trials ,and I dont own any stock.

lol

when I was in London a thing that really interested me was Asset Stripping. And low and behold when the seminal book on Slater Walker was being prepared, Charles Raw asked me to type it for him.

(that's because I was friends with his editor at the Sunday Times)

okay... so you reminded me of that when you said you didn't own the stock...
Slater used to tip stocks he did own...